Allogenic stem cell transplantation+1
Not yet recruitingImmunogenicity and safety of RSV A/B prefusion F protein vaccine versus RSV F glycoprotein recombinant adjuvanted vaccine in lung and stem cell transplant recipients
Immunogenicity and safety of RSV A/B prefusion F protein vaccine versus RSV F glycoprotein recombinant adjuvanted vaccine in lung and stem cell transplant recipients
- Disease:Allogenic stem cell transplantationLung transplant
- Substances:GSKVx000000017064RESPIRATORY SYNCYTIAL VIRUS, SUBGROUP A, STABILIZED PREFUSION F PROTEIN 847A+1
France- Participants:18–64 years · 65+ years
- Substances:GSKVx000000017064
- Sponsor:Hospices Civils De Lyon







